Cherry Creek Investment Advisors, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Cherry Creek Investment Advisors, Inc.
- $187 Million
- Q1 2025
A detailed history of Cherry Creek Investment Advisors, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Cherry Creek Investment Advisors, Inc. holds 63,597 shares of RXRX stock, worth $358,051. This represents 0.18% of its overall portfolio holdings.
Number of Shares
63,597
Previous 62,127
2.37%
Holding current value
$358,051
Previous $419,000
19.81%
% of portfolio
0.18%
Previous 0.21%
Shares
6 transactions
Others Institutions Holding RXRX
# of Institutions
345Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$191 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$182 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$140 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$97.5 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$82.6 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.02B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...